February 27, 2020

Vigene Biosciences Awarded Patent for improvements in the packaging efficiency of recombinantly-modified adeno-associated virus (AAV).

ROCKVILLE, Md. – February 24, 2020 – Vigene Biosciences, Inc. (Vigene), a leading biotechnology company for viral vector production and […]
February 27, 2020

Vigene and ASC Therapeutics Announce Long-Term Strategic Partnership for Gene Therapy Development and Manufacturing

ROCKVILLE, Md. Vigene Biosciences, Inc. (Vigene), a leading biotechnology company for viral vector production and development for cell and gene […]
February 27, 2020

Vigene Biosciences Opens State-Of-The-Art Headquarters in Rockville, MD Major addition to Maryland’s biotech corridor with the mission to make gene therapy affordable

ROCKVILLE, MD – January 29, 2020 – Vigene Biosciences, Inc. (Vigene), a pioneer in the viral gene delivery space, unveils […]
February 27, 2020

Vigene Biosciences Secures Institutional Investment in New Round of Growth Capital Financing, April 29, 2019

Rockville, MD. – April 29, 2019 – Vigene Biosciences, Inc (“Vigene”) a leading provider of viral vector products and services […]
December 18, 2018

Vigene Biosciences announces partnership with Virovek to make high yield cGMP AAV production technology accessible and affordable.

ROCKVILLE, Md. Vigene Biosciences, Inc. (Vigene), a leading biotechnology company for viral vector production and development, announced today that the […]
August 15, 2018

Vigene Biosciences Ranks 81st on the 2018 Inc. 5000.

ROCKVILLE, Md. Inc. magazine today revealed that Vigene Biosciences is No. 81 on its 37th annual Inc. 5000, the most prestigious […]
May 29, 2018

Vigene Biosciences Named Emerging Growth Company of the Year at 2018 Corporate Growth Awards.

ROCKVILLE, Md. Vigene Biosciences, Inc. has been recognized as the 2018 Emerging Growth Company of the Year by ACG National […]
November 7, 2017

Vigene Biosciences Partners with The Michael J. Fox Foundation to Distribute Alpha-synuclein Knockdown Viral Vectors for Parkinson’s Disease Research

ROCKVILLE, Maryland – Vigene Biosciences, Inc. (Vigene), a leading biotechnology company for viral vector production and development, today announced a […]
November 1, 2017

Vigene Biosciences and Mila’s Miracle Foundation announce partnership on Gene therapy for CLN7 Batten Disease

A race to save children’s lives from a devastating neurodegenerative disorder ROCKVILLE, Md. ROCKVILLE, Maryland – Vigene Biosciences, Inc. (Vigene), a […]
November 29, 2016

Vigene Biosciences Acquires the cGMP Manufacturing Facility and Assets of Omnia Biologics

Vigene Biosciences, Inc. (Vigene), a leading biotechnology company for viral vector production and development, announced today that the company has […]